Business Segments · Provision for income taxes
Business Segments — Provision for income taxes
Neurocrine Biosciences Business Segments — Provision for income taxes decreased by 42.9% to $48.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 619.1%, from $6.80M to $48.90M. Over 3 years (FY 2022 to FY 2025), Business Segments — Provision for income taxes shows an upward trend with a 56.3% CAGR.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
Rolls up toIncome Tax
How to read this metric
Changes are typically driven by fluctuations in pre-tax income or changes in tax legislation.
Detailed definition
The estimated tax expense calculated on the company's pre-tax earnings based on applicable tax laws. This reflects the c...
Peer comparison
Standard accounting metric; compared against statutory tax rates to evaluate tax planning effectiveness.
Metric ID:
nbix_segment_reportable_segment_provision_for_income_taxesHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.85M | $14.85M | $14.85M | $14.85M | $20.60M | $20.60M | $20.60M | $20.60M | -$8.90M | $33.60M | $60.50M | $59.50M | $6.80M | $52.00M | $82.30M | $85.70M | $48.90M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +38.7% | +0.0% | +0.0% | +0.0% | -143.2% | +477.5% | +80.1% | -1.7% | -88.6% | +664.7% | +58.3% | +4.1% | -42.9% |
| YoY Change | — | — | — | — | +38.7% | +38.7% | +38.7% | +38.7% | -143.2% | +63.1% | +193.7% | +188.8% | +176.4% | +54.8% | +36.0% | +44.0% | +619.1% |
Range-$8.90M – $85.70M
CAGR+34.7%
Avg YoY Growth+106.7%
Median YoY Growth+44.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's business segments — provision for income taxes?
- Neurocrine Biosciences (NBIX) reported business segments — provision for income taxes of $48.90M in Q1 2026.
- How has Neurocrine Biosciences's business segments — provision for income taxes changed year-over-year?
- Neurocrine Biosciences's business segments — provision for income taxes increased by 619.1% year-over-year, from $6.80M to $48.90M.
- What is the long-term trend for Neurocrine Biosciences's business segments — provision for income taxes?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's business segments — provision for income taxes has grown at a 56.3% compound annual growth rate (CAGR), from $59.40M to $226.80M.
- What does business segments — provision for income taxes mean?
- The amount of money the company sets aside for income tax payments.